NURIX THERAPEUTICS INC

Ticker: NRIX CUSIP: 67080M103 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 537,500 Value ($000) $10,196 Avg Close $14.37 Range $8.85 - $22.50

Q3 2025

Shares 347,500 Value ($000) $3,211 Avg Close $10.38 Range $8.20 - $14.56

Q2 2025

Shares 185,000 Value ($000) $2,107 Avg Close $10.81 Range $8.18 - $13.09

Q1 2025

Shares 249,336 Value ($000) $2,962 Avg Close $16.73 Range $11.38 - $20.66

Q4 2024

Shares 290,000 Value ($000) $5,464 Avg Close $22.92 Range $18.31 - $29.56

Q3 2024

Shares 300,000 Value ($000) $6,741 Avg Close $22.65 Range $17.63 - $26.31

Q2 2024

Shares 174,393 Value ($000) $3,640 Avg Close $15.57 Range $11.90 - $22.44

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	537,500	$10,196	$14.37	$8.85 - $22.50
Q3 2025	347,500	$3,211	$10.38	$8.20 - $14.56
Q2 2025	185,000	$2,107	$10.81	$8.18 - $13.09
Q1 2025	249,336	$2,962	$16.73	$11.38 - $20.66
Q4 2024	290,000	$5,464	$22.92	$18.31 - $29.56
Q3 2024	300,000	$6,741	$22.65	$17.63 - $26.31
Q2 2024	174,393	$3,640	$15.57	$11.90 - $22.44